Search research articles
Contact Us
Filters
Showing results (21-30 of 42) with videos related to
Page
of 5
Sort By:
Transplantation and Cellular Therapy
|
May 6, 2024
Persistent Impairment in Immune Reconstitution and Worse Survival Outcomes in Allogeneic Stem Cell Transplantation Patients with Early Coronavirus Disease 2019 Infection
Benjamin J Lee, Pongthep Vittayawacharin, Shawn P Griffin, et al.
Transplantation and Cellular Therapy
|
March 6, 2023
Once-Daily Foscarnet Is Effective for Human Herpesvirus 6 Reactivation after Hematopoietic Stem Cell Transplantation
Pongthep Vittayawacharin, Ghayda' E'Leimat, Benjamin J Lee, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
March 28, 2025
CLO25-058: First-in-Human, Multicenter Phase 1 Study of the Bromodomain 2 Inhibitor ABBV-744 in Relapsed/Refractory Acute Myeloid Leukemia
Anjali Advani, Olatoyosi Odenike, Deepa Jeyakumar, et al.
European Journal of Haematology
|
November 7, 2023
HyperCVAD versus pegaspargase-containing regimens for Hispanic adults with newly diagnosed B-cell acute lymphoblastic leukemia
Benjamin J Lee, Shawn P Griffin, Jean Doh, et al.
British Journal of Haematology
|
November 12, 2025
Venetoclax combined with cladribine, idarubicin, cytarabine (CLIA-VEN) results in higher remission rates over conventional 7 + 3 chemotherapy without increased toxicity in newly diagnosed acute myeloid leukaemia
Benjamin J Lee, Shawn P Griffin, Jean Doh, et al.
Acta Haematologica
|
December 7, 2023
Strategies to Mitigate the Drug-Drug Interaction between Nirmatrelvir/Ritonavir and Tacrolimus in Allogeneic Hematopoietic Stem Cell Transplant Recipients on Azole Antifungals: Results of a Case Series
Shawn P Griffin, Benjamin Lee, Jean Doh, et al.
Leukemia & Lymphoma
|
December 17, 2024
CPX-351 plus gemtuzumab ozogamicin for relapsed/refractory acute myelogenous leukemia: a University of California Hematologic Malignancies Consortium trial
Caspian Oliai, Sunmin Park, Lloyd E Damon, et al.
Bone Marrow Transplantation
|
April 22, 2025
Narsoplimab for refractory transplantation-associated thrombotic microangiopathy (TA-TMA) in adult patients receiving allogeneic hematopoietic stem cell transplantation (AHSCT)
Piyatida Chumnumsiriwath, Pongthep Vittayawacharin, Jorge Ramos-Perez, et al.
Leukemia Research
|
June 6, 2025
A phase 1 trial of ibrutinib and azacitidine for higher risk myelodysplastic syndromes (University of California Hematologic Malignancies Consortium Study 1503)
Brian A Jonas, Samantha C Fisch, Peter T Curtin, et al.
Hematological Oncology
|
April 22, 2023
A phase 1b study of venetoclax and alvocidib in patients with relapsed/refractory acute myeloid leukemia
Brian A Jonas, Jing-Zhou Hou, Gail J Roboz, et al.
Page
of 5
Search research articles
Search
Showing results (21-30 of 42) with videos related to
Sort By:
Page
of 5
Transplantation and Cellular Therapy
|
May 6, 2024
Persistent Impairment in Immune Reconstitution and Worse Survival Outcomes in Allogeneic Stem Cell Transplantation Patients with Early Coronavirus Disease 2019 Infection
Benjamin J Lee, Pongthep Vittayawacharin, Shawn P Griffin, et al.
Transplantation and Cellular Therapy
|
March 6, 2023
Once-Daily Foscarnet Is Effective for Human Herpesvirus 6 Reactivation after Hematopoietic Stem Cell Transplantation
Pongthep Vittayawacharin, Ghayda' E'Leimat, Benjamin J Lee, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
March 28, 2025
CLO25-058: First-in-Human, Multicenter Phase 1 Study of the Bromodomain 2 Inhibitor ABBV-744 in Relapsed/Refractory Acute Myeloid Leukemia
Anjali Advani, Olatoyosi Odenike, Deepa Jeyakumar, et al.
European Journal of Haematology
|
November 7, 2023
HyperCVAD versus pegaspargase-containing regimens for Hispanic adults with newly diagnosed B-cell acute lymphoblastic leukemia
Benjamin J Lee, Shawn P Griffin, Jean Doh, et al.
British Journal of Haematology
|
November 12, 2025
Venetoclax combined with cladribine, idarubicin, cytarabine (CLIA-VEN) results in higher remission rates over conventional 7 + 3 chemotherapy without increased toxicity in newly diagnosed acute myeloid leukaemia
Benjamin J Lee, Shawn P Griffin, Jean Doh, et al.
Acta Haematologica
|
December 7, 2023
Strategies to Mitigate the Drug-Drug Interaction between Nirmatrelvir/Ritonavir and Tacrolimus in Allogeneic Hematopoietic Stem Cell Transplant Recipients on Azole Antifungals: Results of a Case Series
Shawn P Griffin, Benjamin Lee, Jean Doh, et al.
Leukemia & Lymphoma
|
December 17, 2024
CPX-351 plus gemtuzumab ozogamicin for relapsed/refractory acute myelogenous leukemia: a University of California Hematologic Malignancies Consortium trial
Caspian Oliai, Sunmin Park, Lloyd E Damon, et al.
Bone Marrow Transplantation
|
April 22, 2025
Narsoplimab for refractory transplantation-associated thrombotic microangiopathy (TA-TMA) in adult patients receiving allogeneic hematopoietic stem cell transplantation (AHSCT)
Piyatida Chumnumsiriwath, Pongthep Vittayawacharin, Jorge Ramos-Perez, et al.
Leukemia Research
|
June 6, 2025
A phase 1 trial of ibrutinib and azacitidine for higher risk myelodysplastic syndromes (University of California Hematologic Malignancies Consortium Study 1503)
Brian A Jonas, Samantha C Fisch, Peter T Curtin, et al.
Hematological Oncology
|
April 22, 2023
A phase 1b study of venetoclax and alvocidib in patients with relapsed/refractory acute myeloid leukemia
Brian A Jonas, Jing-Zhou Hou, Gail J Roboz, et al.
Page
of 5